|
|
| Line 35: |
Line 35: |
| |} | | |} |
|
| |
|
| ==WHO Essential and Desirable Genetic Diagnostic Criteria==
| |
| {| class="wikitable"
| |
| |+
| |
| |WHO Essential Criteria (Genetics)*
| |
| |Presence of biallelic mutations in ''CEBPA (''bi''CEBPA)'', or a single mutation located in the bZIP region (smbZIP-''CEBPA''); absence of criteria allowing for classification into other AMLs with defining genetic abnormalities
| |
| |-
| |
| |WHO Desirable Criteria (Genetics)*
| |
| |N/A
| |
| |-
| |
| |Other Classification
| |
| |N/A
| |
| |}
| |
| <nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>].
| |
| ==Related Terminology== | | ==Related Terminology== |
|
| |
|
